{"status": "ok", "totalResults": 4, "articles": [{"source": {"id": null, "name": "Financial Times"}, "author": null, "title": "US Federal Reserve chair Jay Powell hails \u2018considerable progress\u2019 in tackling inflation - Financial Times", "description": "Central bank underscores that next US interest rate move is likely to be a cut", "url": "https://www.ft.com/content/07905699-f937-4400-9d8c-fdb2e83890d1", "urlToImage": null, "publishedAt": "2024-07-09T16:21:01Z", "content": "Then $75 per month.Complete digital access to quality FT journalism on any device. Cancel anytime during your trial."}, {"source": {"id": null, "name": "Forbes"}, "author": "Giacomo Tognini", "title": "Billionaire Harvard Professor's Fortune Jumps Nearly $200 Million On News Of Eli Lilly Biotech Deal - Forbes", "description": "Shares of biotech firm Morphic Holding, founded by Harvard immunologist Tim Springer, rocketed up 75% Monday after Eli Lilly said it would snap it up for $3.2 billion.", "url": "https://www.forbes.com/sites/giacomotognini/2024/07/08/billionaire-harvard-professors-fortune-jumps-nearly-200-million-on-news-of-eli-lilly-biotech-deal/", "urlToImage": "https://imageio.forbes.com/specials-images/imageserve/668c3240e51b9cae51daeef8/0x0.jpg?format=jpg&crop=3079,1734,x0,y60,safe&height=900&width=1600&fit=bounds", "publishedAt": "2024-07-08T18:49:52Z", "content": "Timothy Springer.\r\n\u00a9 2018 Bloomberg Finance LP\r\nHarvard professor Timothy Springer first made headlines in 2020 when a biotech company he had invested inModernasuddenly became a household name thanks\u2026 [+4297 chars]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "Financial Times"}, "author": "Joshua Franklin, Stephen Gandel", "title": "Dealmaking revival expected to boost results for Wall Street banks - Financial Times", "description": "Investment revenue is expected to rise 30% over past year as lenders report earnings this week", "url": "https://www.ft.com/content/62f3ab5a-e636-480a-9c74-c30faf07b406", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F2ce45e30-f005-4757-9ea8-363db6c63eaa.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2024-07-07T20:00:29Z", "content": "The early stages of a long-awaited recovery in investment banking fees is set to boost Wall Street lenders when they report second-quarter earnings starting this week, with mergers and debt deals pic\u2026 [+4099 chars]"}]}